Here's how each program compares in 2026
The increase in vision loss claims comes after emerging dataincluding a June 2025 JAMA Ophthalmology studylinked semaglutide use to significantly higher rates of NAION
Additionally, patients with SCD, MCI, or dementia were required to have the ability to provide informed consent, demonstrated by a mini-mental state examination (MMSE) score greater than 17/30
Further, a glutathione conjugate can serve as a marker for the presence of a reactive electrophile providing valid information for the evaluation of a drug candidate
Additional fatigue, though less common, could worsen existing tiredness
No significant changes in lab tests (e.g., blood counts, liver/kidney function) have been observed